|
|
||||||||
Clinical Investigations |
1 Department of Nuclear Medicine, Carmel Medical Center, Haifa, Israel
2 The B. Rapaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel
3 Department of Nuclear Medicine, Rambam Medical Center, Haifa, Israel
4 Department of Epidemiology and Biostatistics, Carmel Medical Center, Haifa, Israel
Glucose metabolic activity expressed as 18F-FDG uptake may be increased in active atherosclerotic plaque. Calcium depositions are often increased in mature atherosclerotic plaque. The purpose of the present study was to assess the patterns of vascular-wall 18F-FDG uptake and CT calcifications using combined PET/CT. Methods: One hundred twenty-two consecutive patients over the age of 50 (47 women and 75 men; mean age, 66 ± 9 y) undergoing whole-body 18F-FDG PET/CT for tumor assessment were retrospectively evaluated. PET, CT, and PET/CT slices were generated for review. Abnormal vascular findings in major arteries in the chest and abdomen were categorized as PET positive (PET+), PET negative (PET), CT positive (CT+), or CT negative (CT). The topographic relationship between increased vascular-wall 18F-FDG uptake on PET and the presence of calcifications on CT was assessed on PET/CT fused images, with abnormal sites further classified as PET+/CT+, PET+/CT, or PET/CT+. The presence of CT calcifications and increased vascular-wall 18F-FDG uptake was correlated with age, sex, presence of cardiovascular risk factors, and cardiovascular disease. Results: Abnormal findings were identified at 349 sites. CT calcifications (CT+) were observed at 320 sites (92%) of 100 patients (82%), more commonly in men (P < 0.03), in older patients (P < 0.0001), in patients with hypertension (P < 0.003) or hyperlipidemia (P < 0.04), and in smokers (P < 0.008). Increased vascular-wall 18F-FDG uptake (PET+) was observed at 52 sites (15%) of 38 patients (31%), more commonly in men (P < 0.02), in older patients (P < 0.0001), and in patients with hypertension (P < 0.02), and was borderline in patients with cardiovascular disease (P = 0.057). PET+ and CT+ findings correlated in 12 patients, a PET+/CT pattern was found in 18 patients, and 8 patients had increased vascular-wall 18F-FDG uptake in sites with and without calcifications (PET+/CT+, CT). Twenty-two patients (18%) had a PET/CT pattern. Conclusion: Hybrid PET/CT can be used to identify and to correctly localize vascular-wall 18F-FDG activity. Increased vascular-wall 18F-FDG activity was found in 15% of sites and CT calcifications were noted in 92% of sites, with congruent findings in 7%. The clinical significance of the relationship between vascular-wall 18F-FDG uptake and CT calcifications needs to be assessed by further prospective studies with long-term follow up.
Key Words: hybrid imaging PET/CT atherosclerosis arterial calcifications
Related articles in JNM:
This article has been cited by other articles:
![]() |
S. J. Lee, Y. K. On, E. J. Lee, J. Y. Choi, B.-T. Kim, and K.-H. Lee Reversal of Vascular 18F-FDG Uptake with Plasma High-Density Lipoprotein Elevation by Atherogenic Risk Reduction J. Nucl. Med., August 1, 2008; 49(8): 1277 - 1282. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. F. Langer, R. Haubner, B. J. Pichler, and M. Gawaz Radionuclide imaging a molecular key to the atherosclerotic plaque. J. Am. Coll. Cardiol., July 1, 2008; 52(1): 1 - 12. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Williams and G. M. Kolodny Suppression of Myocardial 18F-FDG Uptake by Preparing Patients with a High-Fat, Low-Carbohydrate Diet Am. J. Roentgenol., February 1, 2008; 190(2): W151 - W156. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-W. Wu, H.-L. Kao, M.-F. Chen, B.-C. Lee, W.-Y. I. Tseng, J.-S. Jeng, K.-Y. Tzen, R.-F. Yen, P.-J. Huang, and W.-S. Yang Characterization of Plaques Using 18F-FDG PET/CT in Patients with Carotid Atherosclerosis and Correlation with Matrix Metalloproteinase-1 J. Nucl. Med., February 1, 2007; 48(2): 227 - 233. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Israel, M. Weiler-Sagie, S. Rispler, R. Bar-Shalom, A. Frenkel, Z. Keidar, A. Bar-Shalev, and H. W. Strauss PET/CT Quantitation of the Effect of Patient-Related Factors on Cardiac 18F-FDG Uptake J. Nucl. Med., February 1, 2007; 48(2): 234 - 239. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Davies, J. H.F. Rudd, P. L. Weissberg, and J. Narula Radionuclide imaging for the detection of inflammation in vulnerable plaques. J. Am. Coll. Cardiol., April 18, 2006; 47(8 Suppl): C57 - C68. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Matter, M. T. Wyss, P. Meier, N. Spath, T. von Lukowicz, C. Lohmann, B. Weber, A. R. de Molina, J. C. Lacal, S. M. Ametamey, et al. 18F-Choline Images Murine Atherosclerotic Plaques Ex Vivo Arterioscler. Thromb. Vasc. Biol., March 1, 2006; 26(3): 584 - 589. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Davies, J. H.F. Rudd, T. D. Fryer, M. J. Graves, J. C. Clark, P. J. Kirkpatrick, J. H. Gillard, E. A. Warburton, and P. L. Weissberg Identification of Culprit Lesions After Transient Ischemic Attack by Combined 18F Fluorodeoxyglucose Positron-Emission Tomography and High-Resolution Magnetic Resonance Imaging Stroke, December 1, 2005; 36(12): 2642 - 2647. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P.S. Dunphy, A. Freiman, S. M. Larson, and H. W. Strauss Association of Vascular 18F-FDG Uptake with Vascular Calcification J. Nucl. Med., August 1, 2005; 46(8): 1278 - 1284. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Weissberg Noninvasive Imaging of Atherosclerosis: The Biology Behind the Pictures J. Nucl. Med., November 1, 2004; 45(11): 1794 - 1795. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |